497 related articles for article (PubMed ID: 33995661)
41. Nanomedicine to overcome cancer multidrug resistance.
Yang X; Yi C; Luo N; Gong C
Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
[TBL] [Abstract][Full Text] [Related]
42. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
43. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
Ni R; Zhu J; Xu Z; Chen Y
J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
[TBL] [Abstract][Full Text] [Related]
44. Gd-based upconversion nanocarriers with yolk-shell structure for dual-modal imaging and enhanced chemotherapy to overcome multidrug resistance in breast cancer.
Pan Y; Zhang L; Zeng L; Ren W; Xiao X; Zhang J; Zhang L; Li A; Lu G; Wu A
Nanoscale; 2016 Jan; 8(2):878-88. PubMed ID: 26648267
[TBL] [Abstract][Full Text] [Related]
45. SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines.
Wu CP; Murakami M; Hsiao SH; Liu TC; Yeh N; Li YQ; Hung TH; Wu YS; Ambudkar SV
Cancer Lett; 2018 Oct; 433():259-272. PubMed ID: 30026175
[TBL] [Abstract][Full Text] [Related]
46. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
Baghbani F; Moztarzadeh F
Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
[TBL] [Abstract][Full Text] [Related]
47. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
48. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor.
Cai CY; Zhang W; Wang JQ; Lei ZN; Zhang YK; Wang YJ; Gupta P; Tan CP; Wang B; Chen ZS
Biochem Pharmacol; 2020 May; 175():113848. PubMed ID: 32044354
[TBL] [Abstract][Full Text] [Related]
49. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance.
Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645
[TBL] [Abstract][Full Text] [Related]
50. Multidrug resistance: Physiological principles and nanomedical solutions.
Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
[TBL] [Abstract][Full Text] [Related]
51. Dual-functional drug liposomes in treatment of resistant cancers.
Mu LM; Ju RJ; Liu R; Bu YZ; Zhang JY; Li XQ; Zeng F; Lu WL
Adv Drug Deliv Rev; 2017 Jun; 115():46-56. PubMed ID: 28433739
[TBL] [Abstract][Full Text] [Related]
52. IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model.
Gomez-Cabrero A; Wrasidlo W; Reisfeld RA
PLoS One; 2013; 8(8):e73607. PubMed ID: 24014113
[TBL] [Abstract][Full Text] [Related]
53. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
Karthikeyan S; Hoti SL
Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
[TBL] [Abstract][Full Text] [Related]
54. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
56. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
[TBL] [Abstract][Full Text] [Related]
57. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
[TBL] [Abstract][Full Text] [Related]
58. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
Banerjee K; Biswas MK; Choudhuri SK
J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
[TBL] [Abstract][Full Text] [Related]
59. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
Lee CH
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
[TBL] [Abstract][Full Text] [Related]
60. Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors.
Kesharwani SS; Kaur S; Tummala H; Sangamwar AT
Colloids Surf B Biointerfaces; 2019 Jan; 173():581-590. PubMed ID: 30352379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]